 <h1>Amisulpride Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to amisulpride: intravenous solution</i></p><h3>Warning</h3><p>Before you are treated with amisulpride, tell your doctor about all your medical conditions or allergies, all medicines you use, and if you are pregnant or breastfeeding.</p><p>Get emergency medical help if you have signs of an allergic reaction:  hives; difficult breathing; swelling of your face, lips, tongue, or throat.</p><p>Call your doctor at once if you have:</p><ul>
<li>
<p>sudden dizziness (like you might pass out);</p>
</li>
<li>
<p>fast or pounding heartbeats, fluttering in your chest;</p>
</li>
<li>
<p>shortness of breath; or</p>
</li>
<li>
<p>low potassium level--leg cramps, constipation, irregular heartbeats, fluttering in your chest, increased thirst or urination, numbness or tingling, muscle weakness or limp feeling.</p>
</li>
</ul><p>sudden dizziness (like you might pass out);</p><p>fast or pounding heartbeats, fluttering in your chest;</p><p>shortness of breath; or</p><p>low potassium level--leg cramps, constipation, irregular heartbeats, fluttering in your chest, increased thirst or urination, numbness or tingling, muscle weakness or limp feeling.</p><p>Common side effects may include:</p><ul>
<li>
<p>low potassium;</p>
</li>
<li>
<p>feeling light-headed;</p>
</li>
<li>
<p>stomach bloating; or</p>
</li>
<li>
<p>pain where the medicine was injected.</p>
</li>
</ul><p>low potassium;</p><p>feeling light-headed;</p><p>stomach bloating; or</p><p>pain where the medicine was injected.</p><p>This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. </p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to amisulpride: intravenous solution</i></p><h3>General</h3><p>IV: The most commonly reported side effects included infusion site pain, increased serum prolactin, chills, and hypokalemia.</p><p></p><p>Oral: The most commonly reported side effects included extrapyramidal disorder, insomnia, anxiety, and increased weight.<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Acute dystonia was usually reversible without discontinuation of this drug when given concurrently with an antiparkinsonian agent.  Acute dystonia included oculogyric crisis, spasm torticollis, and/or trismus.</p><p></p><p>Extrapyramidal symptoms (EPS) were usually mild at optimal doses, and were partially reversible without discontinuation of this drug when given concurrently with an antiparkinsonian agent.  EPS included akathisia, dyskinesia, hypersalivation, hypokinesia, rigidity, and/or tremor.</p><p></p><p>Neuroleptic malignant syndrome was potentially fatal.</p><p></p><p>Tardive dyskinesia typically occurred after prolonged administration.  Antiparkinsonian agents were ineffective, and/or possibly induced symptom aggravation.<sup>[Ref]</sup></p><p>IV:</p><p><b>Postmarketing reports</b>: Dystonia, extrapyramidal disorder, neuroleptic malignant syndrome, seizure, somnolence</p><p></p><p>Oral:</p><p><b>Very common</b> (10% or more): Extrapyramidal disorder (up to 11%)</p><p><b>Common</b> (1% to 10%): Acute dystonia/dystonia, akathisia, dizziness, dyskinesia, headache, hypokinesia, somnolence, tremor</p><p><b>Uncommon</b> (0.1% to 1%): Seizures, tardive dyskinesia</p><p><b>Rare</b> (0.01% to 0.1%): Neuroleptic malignant syndrome</p><p><b>Frequency not reported</b>: Restless legs syndrome with/without akathisia<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p>IV:</p><p><b>Common</b> (1% to 10%): Abdominal distention</p><p></p><p>Oral:</p><p><b>Common</b> (1% to 10%): Abdominal pain, constipation, diarrhea, dry mouth, dyspepsia, hypersalivation, nausea, vomiting<sup>[Ref]</sup></p><h3>Psychiatric</h3><p>IV:</p><p><b>Postmarketing reports</b>: Agitation, anxiety, confusional state, insomnia</p><p></p><p>Oral:</p><p><b>Common</b> (1% to 10%): Aggressive reaction, agitation, anxiety, depression, insomnia, nervousness, orgasmic dysfunction, suicide attempt</p><p><b>Uncommon</b> (0.1% to 1%): Confusion, sleep-related eating disorder, somnambulism/sleepwalking<sup>[Ref]</sup></p><p>Somnambulism included sleep-related eating disorder and other sleep-related behaviors.<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p>Ventricular arrhythmias included Torsade de pointes and ventricular tachycardia, and may result in cardiac arrest, ventricular fibrillation, and/or sudden death.</p><p></p><p>Venous thromboembolism included deep vein thrombosis and fatal/nonfatal pulmonary embolism.<sup>[Ref]</sup></p><p>IV:</p><p><b>Common</b> (1% to 10%): Procedural hypotension</p><p><b>Postmarketing reports</b>: Bradycardia, hypotension, QT prolongation (by ECG), Torsade de pointes, ventricular tachycardia</p><p></p><p>Oral:</p><p><b>Common</b> (1% to 10%): Hypertension/increased blood pressure, hypotension, postural hypotension, QT interval prolongation</p><p><b>Uncommon</b> (0.1% to 1%): Bradycardia</p><p><b>Rare</b> (0.01% to 0.1%): Cardiac arrest, deep vein thrombosis, Torsade de pointes, venous thromboembolism, ventricular arrhythmias, ventricular fibrillation, ventricular tachycardia<sup>[Ref]</sup></p><h3>Genitourinary</h3><p>Oral:</p><p><b>Common</b> (1% to 10%): Amenorrhea, galactorrhea, menstrual disorder, vaginitis</p><p><b>Uncommon</b> (0.1% to 1%): Urinary retention</p><p><b>Frequency not reported</b>: Breast pain, erectile dysfunction<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p>Oral:</p><p><b>Common</b> (1% to 10%): Rigidity, spasm torticollis, trismus</p><p><b>Uncommon</b> (0.1% to 1%): Osteopenia, osteoporosis<sup>[Ref]</sup></p><h3>Dermatologic</h3><p>IV:</p><p><b>Postmarketing reports</b>: Urticaria</p><p></p><p>Oral:</p><p><b>Common</b> (1% to 10%): Increased sweating, pruritus</p><p><b>Rare</b> (0.01% to 0.1%): Urticaria</p><p><b>Frequency not reported</b>: Photosensitivity reaction<sup>[Ref]</sup></p><h3>Endocrine</h3><p>IV:</p><p><b>Common</b> (1% to 10%): Increased serum prolactin</p><p></p><p>Oral:</p><p><b>Common</b> (1% to 10%): Reversible increase in plasma prolactin levels</p><p><b>Rare</b> (0.01% to 0.1%): Syndrome of inappropriate antidiuretic hormone secretion (SIADH)</p><p><b>Frequency not reported</b>: Gynecomastia<sup>[Ref]</sup></p><p>Female patients given a single, 5 to 10 mg IV dose over 1 to 2 minutes had serum prolactin levels that increased from a baseline of 10 ng/mL to 32 ng/mL; male patients given the same treatment had serum prolactin levels that increased from a baseline of 10 ng/mL to 19 ng/mL.</p><p></p><p>Reversible plasma prolactin level increases (upon drug discontinuation) resulted in amenorrhea, breast pain, erectile dysfunction, galactorrhea, and/or gynecomastia.<sup>[Ref]</sup></p><h3>Other</h3><p>IV:</p><p><b>Common</b> (1% to 10%): Chills</p><p></p><p>Oral:</p><p><b>Common</b> (1% to 10%): Fatigue</p><p><b>Rare</b> (0.01% to 0.1%): Sudden death</p><p><b>Frequency not reported</b>: Neonatal drug withdrawal syndrome<sup>[Ref]</sup></p><h3>Ocular</h3><p>Oral:</p><p><b>Common</b> (1% to 10%): Blurred vision, oculogyric crisis<sup>[Ref]</sup></p><h3>Local</h3><p>IV:</p><p><b>Common</b> (1% to 10%): Infusion site pain<sup>[Ref]</sup></p><h3>Hepatic</h3><p>IV:</p><p><b>Postmarketing reports</b>: Increased liver enzymes</p><p></p><p>Oral:</p><p><b>Uncommon</b> (0.1% to 1%): Hepatocellular injury, liver enzyme elevations, transaminase elevations<sup>[Ref]</sup></p><h3>Respiratory</h3><p>Oral:</p><p><b>Uncommon</b> (0.1% to 1%): Aspiration pneumonia, nasal congestion</p><p><b>Rare</b> (0.01% to 0.1%): Fatal pulmonary embolism, pulmonary embolism<sup>[Ref]</sup></p><p>Aspiration pneumonia usually occurred in combination with other antipsychotics and central nervous system depressants.<sup>[Ref]</sup></p><h3>Hematologic</h3><p>IV:</p><p><b>Postmarketing reports</b>: Agranulocytosis</p><p></p><p>Oral:</p><p><b>Uncommon</b> (0.1% to 1%): Leukopenia, neutropenia</p><p><b>Rare</b> (0.01% to 0.1%): Agranulocytosis<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p>IV:</p><p><b>Postmarketing reports</b>: Angioedema, hypersensitivity</p><p></p><p>Oral:</p><p><b>Uncommon</b> (0.1% to 1%): Allergic reactions</p><p><b>Rare</b> (0.01% to 0.1%): Angioedema<sup>[Ref]</sup></p><h3>Oncologic</h3><p>Oral:</p><p><b>Rare</b> (0.01% to 0.1%): Benign pituitary tumor, prolactinoma<sup>[Ref]</sup></p><h3>Metabolic</h3><p>IV:</p><p><b>Common</b> (1% to 10%): Hypokalemia</p><p></p><p>Oral:</p><p><b>Common</b> (1% to 10%): Decreased weight, increased weight/weight gain</p><p><b>Uncommon</b> (0.1% to 1%): Hypercholesterolemia, hyperglycemia, hypertriglyceridemia</p><p><b>Rare</b> (0.01% to 0.1%): Hyponatremia<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Barhemsys (amisulpride)." Acacia Pharma, Inc, Indianapolis, IN. </p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "Australian Product Information." O 0</p><h2>More about amisulpride</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Espa√±ol</li>
<li>4 Reviews</li>
<li>Drug class: atypical antipsychotics</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Amisulpride Intravenous &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Schizophrenia</li>
<li>Persistent Depressive Disorder</li>
<li>Nausea/Vomiting, Postoperative</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>